Inspection Readiness: A Daily Habit, Not a Last-Minute Project

Inspection readiness is often misunderstood as a project that begins shortly before a regulatory inspection. In reality, the strongest pharmaceutical organizations demonstrate inspection readiness every day through disciplined quality systems and operational excellence. In this episode of The GMP Insider, we discuss why inspection readiness should be embedded into daily operations rather than treated as a periodic initiative. Discussion topics include: • Building effective CAPA programs that prevent recurrence• Conducting robust investigations and meaningful root cause analysis• Maintaining consistent, inspection-ready documentation• The importance of leadership engagement in quality systems• Developing a quality culture that supports continuous compliance Organizations that consistently operate with strong system controls, reliable documentation, and proactive risk management are always prepared for regulatory inspections. Inspection readiness is not about preparing for an auditor. It is about building quality systems that consistently demonstrate control, compliance, and commitment to patient safety. Because inspections do not create problems. They simply reveal what has been happening every day.